A Comprehensive Hepatitis C Viral Kinetic Model Explaining Cure
Eric Snoeck, Pascal Chanu, Marc Lavielle et al. · Clinical Pharmacology & Therapeutics · 2010
We propose a model that characterizes and links the complexity and diversity of clinically observed hepatitis C viral kinetics to sustained virologic response (SVR)-the primary clinical end point of hepatitis C treatment, defined as an undetectable viral load at 24 weeks after completion of treatment)-in patients with chronic hepatitis C (CHC) who have received treatment with peginterferon alpha-2a +/- ribavirin. The new attributes of our hepatitis C viral kinetic model are (i) the implementation of a cure/viral eradication boundary, (ii) employment of all hepatitis C virus (HCV) RNA measurements, including those below the lower limit of quantification (LLOQ), and (iii) implementation of a population modeling approach. The model demonstrated excellent positive (99.3%) and negative (97.1%) predictive values for SVR as well as high sensitivity (96.6%) and specificity (99.4%). The proposed viral kinetic model provides a framework for mechanistic exploration of treatment outcome and permits evaluation of alternative CHC treatment options with the ultimate aim of developing and testing hypotheses for personalizing treatments in this disease.
Cited by 114 works. doi:10.1038/clpt.2010.35
Authors
- Eric Snoeck
- Pascal Chanu
- Marc Lavielle
- Philippe Jacqmin
- E. Niclas Jonsson
- Karin M. Jorga
- Timothy K. Goggin
- Nelson L. ‘Shasha’ Jumbe
- Norbert Frey
References
- Discrete Multivariate Analysis: Theory and Practice.
- Viral dynamics in human immunodeficiency virus type 1 infection
- Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection
- Statistics Notes: Diagnostic tests 1: sensitivity and specificity
- HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time
- Peginterferon-α2a and Ribavirin Combination Therapy in Chronic Hepatitis C
- Peginterferon Alfa-2a in Patients with Chronic Hepatitis C
- Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α Therapy
- Diagnosis, management, and treatment of hepatitis C†
- Peginterferon Alfa-2a in Patients with Chronic Hepatitis C and Cirrhosis